GlassScriptPhysician profile
Jill N Ash
NPI 1275873713
$2,072.36
in general payments reported to CMS, 2019-2025
29 companies · $637 in 2025
The $637 reported for 2025 was more than what 90% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $181 · 2023: $648 · 2024: $477 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,762.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $315.26 | 2023 | Myrisk |
| Mayne Pharma Commercial LLC | $285.16 | 2022-2025 | Annovera |
| Biogen, INC. | $201.81 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $156.45 | 2021-2025 | |
| Astellas Pharma US INC | $145.33 | 2024 | Veozah |
| Sumitomo Pharma America, INC. | $122.91 | 2023-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $98.22 | 2023-2025 | Aptima, Affirm Prone Biopsy System |
| Abbvie INC. | $79.30 | 2021-2023 | |
| Organon LLC | $78.99 | 2022-2025 | Nexplanon |
| Myovant Sciences INC. | $75.23 | 2022 | |
| Evofem Biosciences, INC. | $60.43 | 2021-2024 | Phexxi |
| Exact Sciences Corporation | $56.98 | 2024-2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $52.18 | 2023-2024 | Accrufer |
| Baxter Healthcare | $47.11 | 2025 | Perclot |
| Dexcom, INC. | $33.83 | 2025 | Dexcom G6 Transmitter |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $32.86 | 2024 | On-Q* Pump and Accessories |
| Exeltis, USA INC. | $31.59 | 2022-2023 | Slynd |
| Optumhealth Care Solutions, LLC | $23.63 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Merck Sharp & Dohme LLC | $22.90 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.22 | 2025 | |
| Lupin INC. | $18.31 | 2021 | |
| Ascend Therapeutics US, LLC | $16.44 | 2023 | |
| Millicent US INC | $16.21 | 2025 | Femring, Intrarosa |
| Mission Pharmacal Company | $14.91 | 2021 | |
| Aspira Women'S Health INC | $14.36 | 2024 | Ova1 |
| Coopersurgical, INC. | $14.28 | 2022 | |
| Lilly USA, LLC | $14.06 | 2024 | Zepbound |
| Avion Pharmaceuticals | $12.82 | 2023 | Balcoltra |
| Therapeuticsmd, INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Ash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.